Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-03-010847
Filing Date
2003-03-28
Accepted
2003-03-28 14:57:51
Documents
12
Period of Report
2002-12-29

Document Format Files

Seq Description Document Type Size
1 10-K a2106144z10-k.htm 10-K 584196
3 EXHIBIT 10.6.7 a2106144zex-10_67.txt EX-10.6-7 5052
4 EXHIBIT 10.6.8 a2106144zex-10_68.txt EX-10.6-8 5989
5 EXHIBIT 10.6.9 a2106144zex-10_69.txt EX-10.6-9 2771
6 EXHIBIT 10.20.1 a2106144zex-10_201.txt EX-10.20-1 155337
7 EXHIBIT 10.20.2 a2106144zex-10_202.txt EX-10.20-2 118629
8 EXHIBIT 10.21 a2106144zex-10_21.txt EX-10.21 91100
9 EXHIBIT 10.30 a2106144zex-10_30.txt EX-10.30 25480
10 EXHIBIT 21 a2106144zex-21.txt EX-21 718
11 EXHIBIT 23 a2106144zex-23.txt EX-23 881
12 EXHIBIT 99.1 a2106144zex-99_1.txt EX-99.1 31930
13 EXHIBIT 99.2 a2106144zex-99_2.txt EX-99.2 2777
  Complete submission text file 0001047469-03-010847.txt   1027700
Mailing Address 175 CROSSING BLVD FRAMINGHAM MA 01701
Business Address 175 CROSSING BLVD FRAMINGHAM MA 01701 508620-970
GTC BIOTHERAPEUTICS INC (Filer) CIK: 0000904973 (see all company filings)

EIN.: 043186494 | State of Incorp.: MA | Fiscal Year End: 0103
Type: 10-K | Act: 34 | File No.: 000-21794 | Film No.: 03624706
SIC: 2836 Biological Products, (No Diagnostic Substances)